What is BRAINBox Solutions?
BRAINBox Solutions specializes in a multi-modality approach to aid clinicians in diagnosing mild traumatic brain injury (mTBI) and assessing post-injury symptoms. Their comprehensive offerings include blood biomarker panels, neurocognitive testing, and a point-of-care instrument designed to enhance diagnostic accuracy and provide objective evidence of injury. The company is committed to establishing a new standard of care in TBI assessment, leveraging cutting-edge technology and a team of industry pioneers to address a critical unmet need in neurological diagnostics.
How much funding has BRAINBox Solutions raised?
BRAINBox Solutions has raised a total of $26.6M across 3 funding rounds:
Debt
$150K
Series A
$23M
Grant
$3.5M
Debt (2020): $150K with participation from PPP
Series A (2020): $23M led by Tauber Family Foundation Inc, BioVentures Investors, Genoa VC, Astia, and Pharmakon Holdings
Grant (2022): $3.5M supported by National Institute of Neurological Disorders and Stroke
Key Investors in BRAINBox Solutions
Astia
Astia is a venture capital firm dedicated to investing in high-performing women-led companies. They focus on sectors such as health and aim to create a more equitable venture capital landscape by addressing gender and racial disparities.
BioVentures Investors
BioVentures Investors is likely a venture capital firm specializing in investments within the biotechnology and life sciences sectors, providing capital for companies developing innovative healthcare solutions.
National Institute of Neurological Disorders and Stroke
The National Institute of Neurological Disorders and Stroke (NINDS) is a U.S. government organization dedicated to advancing research and health related to brain and nervous system disorders, providing funding and support for neurological research.
What's next for BRAINBox Solutions?
With the recent infusion of capital, BRAINBox Solutions is poised to accelerate its growth trajectory. The company's strategic investment is expected to fuel further development of its diagnostic platform, support ongoing clinical trials, and facilitate market expansion. This backing positions BRAINBox to potentially revolutionize TBI assessment, offering clinicians more precise tools and patients improved diagnostic certainty and care pathways. The company's focus on objective data and a comprehensive approach signals a strong potential for market leadership in the specialized field of neurological injury diagnostics.
See full BRAINBox Solutions company page
